543207 — Natural Biocon (India) Income Statement
0.000.00%
Last trade - 00:00- IN₹88.69m
- IN₹92.05m
- IN₹25.44m
Annual income statement for Natural Biocon (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.82 | 12.5 | 135 | 83.5 | 25.4 |
| Cost of Revenue | |||||
| Gross Profit | 1.94 | 3.75 | 8.65 | 9.54 | 3.69 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.93 | 10.1 | 133 | 82.9 | 25.9 |
| Operating Profit | 0.887 | 2.48 | 2.25 | 0.605 | -0.413 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.879 | 2.47 | 2.25 | 0.596 | -0.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.659 | 1.79 | 1.53 | 0.446 | -0.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.659 | 1.79 | 1.53 | 0.446 | -0.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.659 | 1.79 | 1.53 | 0.446 | -0.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.058 | 0.157 | 0.134 | 0.02 | -0.02 |